Insider Trading activities at Evommune, Inc. (EVMN)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Evommune, Inc. (EVMN) since 2025 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Evommune, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 2044725.

Total stock buying since 2025: $70,017,350.
Total stock sales since 2025: $1,626,960.
Total stock option exercises since 2025: $121,057.


9 insiders reported insider trading activities at Evommune, Inc. (EVMN):
Insider trading activities of Ra Capital Management, L.p.
Insider trading activities of Pena Luis C.
Insider trading activities of Verduyn-van Weegen Felice Isabel
Insider trading activities of Carver Kyle
Insider trading activities of Lsp 7 Cooperative Ua
Insider trading activities of Hopfner Robert Lorne
Insider trading activities of Cohen David E
Insider trading activities of Patel Jeegar Pravinkumar
Insider trading activities of Moss Gregory S.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Evommune, Inc. (EVMN).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2026 0 $0 71,928 $1,626,960 42,735 $121,057
2025 4,376,000 $70,017,350 0 $0 0 $0

Table 2. Monthly summary of insider trading at Evommune, Inc. (EVMN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2026-06 0 $0 39,530 $887,132 13,512 $51,886
2026-05 0 $0 32,398 $739,828 29,223 $69,171
2025-12 1,000 $17,350 0 $0 0 $0
2025-11 4,375,000 $70,000,000 0 $0 0 $0

Table 3. Detailed insider trading at Evommune, Inc. (EVMN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2026-06-02 Cohen David E Sale 6,056 20.80 125,934
2026-06-01 Patel Jeegar Pravinkumar (Chief Scientific Officer) Sale 16,687 22.74 379,462
2026-06-01 Patel Jeegar Pravinkumar (Chief Scientific Officer) Option Ex 13,512 3.84 51,886
2026-06-01 Pena Luis C. (President & CEO) Sale 16,787 22.74 381,736
2026-05-28 Carver Kyle (Chief Financial Officer) Sale 18,175 22.84 415,117
2026-05-28 Carver Kyle (Chief Financial Officer) Option Ex 15,000 2.99 44,850
2026-05-28 Moss Gregory S. (Chief Business & Legal Officer) Sale 14,223 22.83 324,711
2026-05-28 Moss Gregory S. (Chief Business & Legal Officer) Option Ex 14,223 1.71 24,321
2025-12-19 Hopfner Robert Lorne (Director) Buy 1,000 17.35 17,350
2025-11-07 Verduyn-van Weegen Felice Isabel Buy 1,562,500 16.00 25,000,000
2025-11-07 Lsp 7 Cooperative Ua Buy 1,562,500 16.00 25,000,000
2025-11-07 Ra Capital Management, L.p. Buy 1,250,000 16.00 20,000,000

Insider trading activities including stock purchases, stock sales, and option exercises of EVMN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Evommune, Inc. (symbol EVMN, CIK number 2044725) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.